Immuron (IMRN) Cost of Revenue (2016 - 2025)
Immuron (IMRN) posted Cost of Revenue of $1.6 million for Q2 2025, up 15377.43% on a QoQ basis from $10435.3 in Q3 2024, and up 56.49% year-over-year from $1.0 million in Q2 2024.
Analysis
Immuron (IMRN) Cost of Revenue (2016 - 2025) Analysis & Trends
Immuron has reported Cost of Revenue for 10 years, with the latest figure at $1.6 million in Q2 2025.
- On a quarterly basis, Cost of Revenue rose 56.49% year-over-year to $1.6 million in Q2 2025; TTM through Jun 2025 was $3.0 million, a 95.46% increase from a year earlier, with the FY2026 full-year figure at $2.7 million, up 10758.98% from the prior year.
- Cost of Revenue was $1.6 million for Q2 2025 at Immuron, up from $10435.3 in the prior quarter.
- The five-year high for Cost of Revenue was $1.6 million in Q2 2025, with the low at $508.16 in Q4 2021.
- Average Cost of Revenue over 5 years is $398762.4, with a median of $97526.7 recorded in 2021.
- The sharpest annual moves came in 2021 and 2022: Cost of Revenue sank 91.29% in 2021, then soared 30545.09% in 2022.
- Over 5 years, Cost of Revenue stood at $508.16 in 2021, then jumped by 30545.09% to $155726.0 in 2022, then jumped by 107.16% to $322603.5 in 2023, then slumped by 96.77% to $10435.3 in 2024, then surged by 15377.43% to $1.6 million in 2025.
- The last three Cost of Revenue figures came in at $1.6 million (Q2 2025), $10435.3 (Q3 2024), and $1.0 million (Q2 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 2.81 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 1.58 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 489.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 360.70 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 145.00 Mn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 93.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 298.26 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 776.90 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 284,000.00 |
| 10 | Immuron | 10.28 Mn | 1.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 1.62 Mn |
| Sep 9, 2024 | 10,435.26 |
| Jun 30, 2024 | 1.03 Mn |
| Dec 31, 2023 | 322,603.54 |
| Jun 30, 2023 | 14,310.93 |
| Dec 31, 2022 | 155,726.00 |
| Dec 31, 2021 | 508.16 |
| Jun 30, 2021 | 39,327.49 |
| Dec 31, 2020 | 91.25 |
| Jun 30, 2020 | 451,477.32 |
| Dec 31, 2019 | 4,351.98 |
| Dec 31, 2018 | 231,479.00 |
| Dec 31, 2017 | 150,236.30 |
| Dec 31, 2016 | 168,434.17 |
| Jun 30, 2016 | 225,082.24 |